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ABSTRACT 
Type 2 Diabetes and the Risk of Osteoporotic Hip Fracture in Utah Men and Women 
by 
Megan Bunch, Master of Science 
Utah State University, 2006 
Major Professor: Dr. Ronald G. Munger 
Department: Nutrition and Food Sciences 
Prior studies have unequivocally established a consistent association between 
osteoporotic hip fracture risk and type 2 diabetes mellitus. One reason this 
association still remains unclear is primarily due to the limited amount of research 
conducted in this area. The Utah Study of Nutrition and Bone Health (USNBH) is a 
case-control study conducted in Utah during the period of 1997-2001 to determine 
risk factors for osteoporotic hip fracture. All study participants (n = 2590) were 
determined from Utal1 residents 50-90 years of age. Cases were determined from 18 
Utah hospitals during 1997-2001. Age and gender-matched controls were randomly 
selected from the Utah Drivers License pool if less than 65 years of age and the 
Medicare databases if greater than 65 years of age. Logistic regression models were 
used to determine the association between type 2 diabetes and hip fracture risk. 
Logistic regression modeling controlled for gender, body mass index , smoking status, 
lV 
alcohol use, physical activity , education level, and estrogen use in women. The risk 
of hip fracture was associated with type 2 diabetes. The significant correlation was 
primarily found in females in which the risk of hip fracture increased accompanying 
diagnosis of type 2 diabetes. Estrogen usage in females decreased (p < 0.0001) hip 
fracture risk in both former or current users. Physical activity significantly decreased 
the risk of hip fracture for females (p < 0.0001) and for males (p = 0.001). Smoking 
and alcohol use may increase the risk of hip fracture, especially in women. This 
study substantiates the hypothesis that type 2 diabetes mellitus increases the risk of 
hip fracture. 
(62 pages) 
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INTRODUCTION 
The Utah Study of Nutrition and Bone Health (USNBH) was a case-control 
study conducted in Utah during the period of 1997-2001 to determine risk factors for 
osteoporotic hip fractures. All study participants were determined from Utah 
residents aged 50-90 years. The intent of this segment of the USNBH sh1dy was to 
verify putative factors associated with complications of type 2 diabetes mellitus and 
osteoporotic hip :fracture. 
REVIEW OF LITERATURE 
Osteoporosis 
Osteoporosis is a systemic skeletal disorder characterized by low bone mass 
and deterioration of bone leading to bone fragility and susceptibility to fractures (1 ). 
The 1990 Consensus Development Panel defined osteoporosis as a "disease 
characterized by low bone mass and microarchitectural deterioration of bone tissue, 
leading to enhanced bone fragility and increase in fracture risk." (2). 
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Bone loss is a natural process of aging occurring in both genders following 
peak bone mass attainment. Peak bone mass is attained by approximately 25 years of 
age (3). Bone loss can be attributed to failure to achieve optimal peak bone mass and 
impaired bone formation during bone modeling processes (4). Hunter et al. (5) 
reported that many studies have determined marked bone loss in persons 30 to 40 
years of age. Bone loss in males is approximately two-thirds that of women (5). 
Beginning in the middle of the third decade, women lose approximately 35% 
of their cortical bone and 50% of their trabecular bone ( 5). During the first year of 
menopause, an immediate reduction in bone mass occurs due to an accelerated rate of 
bone loss. The increased rate lasts nearly 10 years after menopause followed by 
continuous age-related bone loss (5). An average reduction in bone mineral density 
(BMD) ai:nong postmenopausaL.wornen-not-recei-¥-rng hormonexeplacement therapy 
for a period of 10 years has been associated with a doubling in fracture risk (2). 
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There is not a good explanation for bone deterioration (2). Bone tissue 
continuously undergoes remodeling to replace old bone tissue with new bone ti·ssue. 
Bone remodeling involves mesenchymal osteoblastic activities for bone formation 
and hematopoietic osteoclastic activities for bone resorption ( 4,6). Homeostatic 
imbalance in the remodeling process leads to increased bone resorption and decreased 
bone formation. In addition, bone resorption may create weakened trabecular 
structures resulting in deterioration of bone tissue (2,3,6). 
Osteoporosis is typically asymptomatic until a fracture occurs, although one in 
five women will not be diagnosed with osteoporosis even after a fracture occurs (7). 
As a result of the asymptomatic nature of osteoporosis, it is likely that the actual 
prevalence of osteoporosis is lmderestimated (7). Clinical diagnosis of osteoporosis 
is generally confirmed by low BMD. However, diagnosis of osteoporosis is also 
confirmed on the basis of personal history of osteoporotic fractures at any given time 
(2). The World Health Organization has defined low BMD as greater than 2.5 
standard deviations below the mean BMD values for healthy adults 30-40 years of 
age (2). 
Osteoporosis is the most prevalent metabolic bone disorder in the United 
States (3). The National Institutes of Health Consensus Development Panel on 
Osteoporosis Prevention , Diagnosis , and Therapy reported that in the United States , 
10 million people have osteoporosis and 18 million more have low BMD (8). The 
third National Health and Nutrition Examination Survey (NHANES III) reported that 
34-50% of postmenopausal women have osteopenia, a decrease in calcification of 
density of bone, and 17-20% have osteoporosis (7). By ages 60 to 70 years, only 1 in 
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9 women in the United States have defined normal BMD. Moreover, 1 in 3 women 
have defined osteoporosis (2) . The World Health Organization defines the disease 
state of osteopenia as having a BMD of 1 to 2.5 SDs below the young-adult mean (2). 
Both osteopenia and osteoporosis increase fracture risk, although osteoporosis has the 
greater impact (7). A 1 SD reduction in BMD may account for a 50-100% increase in 
nonspine fractures (5). More than half of all women and nearly one third of all men 
will experience an osteoporotic related fracture during their lifetime (2). 
Approx imatel y 1 in 12 men will sustain an osteoporotic related fracture in their 
lifetime (9). One in six Caucasian women will sustain a hip fracture during their 
lifetime ( 1 0, 11 ). The incidence of hip fracture exponentially increases after 50 years 
of age (2, 12, 13). After age 50, the incidence ratio of hip fractures in women to men 
i approx imately 2 to 1 (1). The lifetime risk of sustaining a hip fracture has been 
estimate d at 17% for Caucasian women and 6% for Caucasian men in the United 
States (14). In the United States, approximately 55% of all hip fractures occur among 
people 80 years of age and older. Of that percentage, approximately 33% occur after 
the age of 85 years (2). 
There are two classifications of osteoporosis, type 1 osteoporosis also referred 
to as menopausal and type 2 osteoporosis also referred to as senile osteoporosis 
( 4,5,8). Type 1 osteoporosis is related to estrogen deficiency after menopause (3). 
Type 1 osteoporosis is typically observed in women less than 65 years of age 
affecting 5-25% of early post-menopausal women (5). Type 2 osteoporosis is 
observed in both women and men with a ratio of 2 women for every 1 man 
approximately 75 years of age or older (3). Once peak bone mass has been attained , 
the prevalence of a bone loss pattern in type 2 osteoporosis is universally observed 
(5). Hip fractures a.re the main consequence of type 2 osteoporosis (3). The 
incidence of hip fractures begins to rise when men reach their late 60s and parallels 
the rise in women in their early 60s (15). 
In 1995, the National Osteoporosis Foundation reported the a1mual cost of 
osteoporotic fractures to be about $13. 8 billion (7). This amount is expected to 
double over the next 25 years due to increases in the elderly population (7). The 
projected total cost for hip fractures in the year 2050 is $131.5 billion (16). Half of 
all health care costs attributed to hip fracture patients is used for nursing home 
facilities (2). Nearly one third of all individuals who have sustained a hip fracture in 
the last year will be discharged to a nursing home (8). When men sustain a hip 
fraclure , the mortality rate is higher than that of women (15, 17, 18). During the first 
year after sustaining a hip fracture, the mortality rate is 36% for men and 21 % for 
women (7). Mortality after sustaining a hip fracture may be a marker of underlying 
disease states ( 19). 
The majority of osteoporotic fractures in the elderly population are due to 
minor to moderate trauma that typically would not occur in younger adult 
populations. Mild to moderate trauma resulting in a fracture is defined as a fall from 
standing height or lower (2). Approximately 90% of the elderly population that 
experience a hip or wrist fracture in the United States is due to mild to moderate 
trauma (2). 
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The spine is the most common osteoporotic fracture site (2). Due to a lack of 
painful symptoms , only one-third of the vertebral fractures are diagnosed, and they 
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dramatically increase after 65 years of age (2). Whenever a vertebral fracture 
occurs , it is a strong indicator that additional vertebral fractures have, or will occur. It 
has been reported that about 50% of women 80 years or older have vertebral 
deformities due to previous vertebral fractures (2). Nearly half of all women with 
vertebral fractures have two or more deformities (2). 
The amrnal rate of hip fractures is predicated to triple by the year 2040 (2). 
Functional disability greatly declines within the first year of a hip fracture (2). 
Reduced functionality results in increased fall rates that further exacerbate 
susceptibility for another hip fracture and lead to greater deterioration of physical 
capacity (2). 
The incidence of wrist fractures substantially increases an1ong women after 
menopause , but levels off after 65 years of age (2). The plateau affect observed after 
65 years of age may be due to the increased rate of older women falling forward on 
outstretched hands (2). Women who have sustained wrist fractures have increased 
hip fracture risks ( 10). 
Several known risk factors (Table 1) for osteoporosis and associated hip 
fracture risk include: cigarette smoking, low body weight (<127 lbs), tall stature, 
estrogen, deficiency, low calcium intake, excessive alcohol intake, inadequate 
physical activity, falls, various medications , chronic conditions, Caucasian race, age, 
female gender, dementia, frailty, history of fracture in first-degree relatives, and 
personal history of fractures (2, 7,10, 11, 12, 13). Some studies have reported lower 
BMD and increased risk of fractures with cigarette smoking . Increased risk of 
fractures also may be due to loss of low body weight increases the risk for hip 
fracture (2,5 , 7, l 0, 11,20,21 ) . 
Table 1. Risk Factors for Osteoporotic Hip Fractures 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
Female sex 
Caucasian descent 
Increasing age 
Cigarette smoking 
Low body weight 
Tall statue 
Estrogen deficiency 
Low calcium intake 
Excessive alcohol intake 
Inadequate physical activity 
Medications ( e.g. glucocorticosteroids , antiseizure medications, hormone 
suppressants) 
Chronic conditions (e.g. thyroid disorders, diabetes mellitus , renal disease) 
Dementia 
Frailty 
History of fractures in first degree relatives 
Personal history of fractures 
Low body weight also may result in low BMD and thereby increase fracture 
risk (2). Low body weight has also been associated with preexisting conditions that 
increase fracture risk (2). Decreased adipose tissue in the body cavity may decrease 
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endogenous estrogen activity, which then can lead to bone loss and increased fracture 
risk (7 ,20,21 ,22). In addition, adipose tissue surrounding the femoral hip may not 
provide suffic ient protection in leaner people. In the event of a fall, a loss of adipose 
tissue can increase the risk of fracture (2,21,22). Moreover , it has been suggested that 
the most consistent predictor of BMD is total body fat (22,23 ). Hence, greater total 
body fat results in elevated BMD. 
Tall women have an increased risk of hip fracture (10,11). The increased 
fracture risk may be due to a longer hip-axis (10). Tall women also have a greater 
distance to fall, which increases hip fracture risk (10). 
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Estrogen deficiency in premenopausal women or estrogen deficiency due to 
menopause accelerates bone loss (2,4,24,25). BMD losses of 2-4% occur up to 5 to 
10 years after menopause in the absence of estrogen replacement therapy (2). 
Smoking is a significant risk factor for osteoporosis and hip fracture 
(10,15,26). Smoking increases the risk for osteoporosis by inducing premature 
menopause. Smoking also causes increased metabolic breakdown of estrogen that 
increases bone loss (5). Estrogen breakdown increases bone remodeling and 
osteoclastic activity (27). Orwoll et al. (28) reported smoking in men 60 years of age 
and older was associated with lower BMD (28). 
Excessive alcohol intake is a strong risk factor for bone loss and fractures 
(2, 15). Excessive alcohol intake may impair osteoblastic activity. Furthermore, high 
consumption of alcohol may lead to protein and/or calcium malnutrition, reduced 
mobility , and hypogonadism (5). Clu-onic alcohol use may increase fracture risk due 
to increased fall rates and hepatic disease (2). Hepatic encephalopathy, resulting in 
decreased cognitive ability, may lead to increased fall rates as a result of decreased 
functionality and cognitive capacity. 
Sedentary living is a strong risk factor for bone loss and fractures (2, 7, 10,22). 
Physical activity , in particular bone building exercises , help to maintain or possibly 
increase BMD and thereby reduce fracture risk (29,30). Epidemiological studies have 
sugge sted that hip fracture risk decreases by 20% to 50% for physically active adults 
compared to sedentary adults in the United States (31 ). Even after attainment of 
peak bone mass, bone tissue can adapt to mechanical loading promoting bone 
remodeling. If physical activity is absent , then reduction in bone mass often ensues 
(30 ,31 ). Other possible benefits of physical activity may include improved agility 
and coordination , as well as increased muscle strength that may lower the likelihood 
of experiencing a fall , and therefore reducing fracture risk (2,29,30,32). 
Increased fall rates may largely affect hip fracture risk rather than vertebral 
fracture risk (2). Vertebral fractures primarily occur spontaneously from bone 
deterioration and low BMD, combined with minimal trauma of low impact forces 
such as bending or lifting (2). Fall mechanics may play a role in the etiology of hip 
fracture . Falls to the side with impact to the hip or side of the leg increases hip 
fracture risk (33). 
African American women, Hispanic women, and Asian women have a lower 
fall incidence compared to Caucasian women (1,2). Nearly 20% of Caucasian 
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women 60-64 years of age and 30% of Caucasian women 80-84 years of age fall 
ammally (2). Hip fractures occur twice as often in Caucasian women compared to 
African American , Asian , and Hispanic women (2). It appears however , that of the 
Hispanic subgroup populations, Mexican Americans have the highest hip fracture risk 
although hip fracture incidence rate is lower than Caucasians (34) . The lower hip 
fracture incidence in African Americans may be due to overall high BMD levels (2). 
Lower hip fracture risk in the Japanese populations is most likely related to lower fall 
rates as well as different femoral hip geometry compared to other populations (2). 
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Long-term usage of corticosteroids may result in decreased BMD and 
increased fracture risk (2). Fitzpatrick (35) reported that BMD is reduced 40-60% in 
patients with endogenous glucocorticoid excess and pathologic fractures have been 
observed in 16-67% of the patients (35) . In addition, hip fracture risk doubled in the 
glucocorticoid treated patients (35). Glucocorticoid induced bone resorption may 
also be in part due to secondary hyperparathyroidism and hypogonadism (15,35). 
Long-term elevation of parathyroid hormone (PTH) levels increases osteoclast bone 
resorption (35,36). Furthermore, glucocorticoid therapy inhibits insulin-like growth 
factor (IGF) synthesis. IGF-1 is synthesized by bone cells and stimulates bone cell 
replication and collagen synthesis (35,37 ,38). Glucocorticoids may also affect IGF-
binding proteins leading to inhibition ofIGF activity. Glucocorticoid therapy may 
give an overall effect to reduce bone formation by decreasing IGF-binding protein 3, 
IGF-binding protein 4, and IGF-binding protein 5 (35). 
Anticonvulsants and other medications may also contribute to bone loss. 
Drug interactions and the conditions for which certain drugs are prescribed also 
impact bone mass (2). Bone disease associated with convulsant therapy may lead to 
high-turnover osteoporosis. Furthermore, seizure episodes may increase hip fracture 
risk (35). 
Chronic health conditions contribute to poor bone health. Low body weight is 
a strong risk factor for hip fractures and may be a consequence of chronic disease 
(2,3, 10, 11 ). Several disease states associated with bone loss and fracture incidence 
include hypogonadism, renal disease, dementia and cognitive impairment, 
cardiovascular disease , diabetes mellitus, stroke, hyperthyroidism , and 
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hyperparathyroidism (2,3,39). Both hyperthyro idism and hyperparath yroidisrn can 
stimul ate bone formation as well as bone resorption (4,35,36). Consequently, if 
osteob lastic cells are not significantly responsive , bone loss may occur. Ahmed et al. 
( 12) reported increased fracture risk in women with hypothyroidism or 
hyperthyroidism (12). Secondary hyperparath yro idism can be caused by intestinal 
malabsorption and renal disease associated with vitamin D metabolism impairment 
(15,36,40,41). 
PTH levels increases with age and is present in higher concentrations in the 
elderly and those persons who have previously sustained hip fractures. Increased 
PTH levels may result in increased bone turnover (40,42). Furthermore, low serum 
25-hydroxyvita min D levels are often observed in the elderly population are often 
assoc iated with high serum PTH levels. Higher leve ls may accelerate bone loss and 
thereby increas e hip fracture risk (36). 
Aluminum induced osteomalacia may be observed in hemodialy sis patients 
(35). Aluminum inhibits bone mineralization and phosphate absorption. Aluminum 
induced osteomalacia may increase serum phosphate levels and lower 1,25-
dihydroxyvitamin D levels (35). 
Cummings et al. ( 10) reported that a woman, whose mother sustained a hip 
fracture, especially before 80 years of age, doubled the likelihood of sustaining a hip 
fracture during her lifetime compared to controls (10). The increased hip fracture risk 
was independent of BMD , weight, and height (10). 
It has been rep01ted that genetics accounts for 50-60% of peak bone mass 
( 15, 17). Seeman (27) reported that twin studies and family member studies have 
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found that differences in bone size, shape, and BMD of individuals of the same age 
are likely due to genetic rather than environmental differences , although no genes 
have been consistently shown to account for the differences (1,27). It has been 
suggested that several genes rather than one or two genes with major effects account 
for bone mass regulation (1). Seeman (27) stated that the inconsistencies may be due 
to poorly defined phenotypes, and that fractures are too rare to define an association 
of genes to bone size, shape, and BMD (27). 
Fractures have been associated with lower BMD (28). And, a previous history 
of fractures has been associated with an increased risk for future fractures (2,41 ,43). 
Adults who sustain a fracture , are 50% to 100% more likely to sustain a subsequent 
fracture (14). The risk of a future fracture increases 2 to 3 times for each previous 
fracture (2). Ross (2) stated that among women greater than 80 years of age who had 
a history of wrist fractures, 30% of those women subsequently experienced a hip 
fracture during their lifetime (2). 
Diabetes Mellitus 
Diabetes mellitus is defined as a heterogeneous group of conditions 
represented by increased serum glucose concentrations , carbohydrate, fat, and protein 
metabolism abnormalities, and the propensity to develop marked, specific forms of 
renal , ocular , neurologic , and premature cardiovascular diseases ( 44,45,46). The 
exact pathogenesis and etiology of diabetes mellitus is not known (44 ,45,46). 
Conditional diagnosis of diabetes is made with a normal fasting plasma glucose 
(FPG) level greater than 7.0 1m11ol/L (126 mg/dL) (44,45,46,47). It is 
recommended that FPG be tested different days to confirm diagnosis of diabetes 
( 44 ,45,46). 
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Although the classification of diabetes type may be unclear due to definition 
over -lap , it falls into several general types: type 1 diabetes and idiopathic type 1 
diabetes, type 2 diabetes , gestational diabetes , and other specific types of diabetes that 
are considered primarily risk factors for another diabetes type ( 46). 
Type 1 diabetes is an immunologicall y mediated and genetically linked 
disorder ( 41 ). Genetic predisposition to type 1 diabetes is strongly associated with 
HLA-DQ and DR on the short arm of chromosome 6 ( 45). Furthermore, the insulin 
gene on chromosome 11 and the cytotoxic I-lymphocyte antigen gene on 
chromosome 2 may be associated with type 1 diabetes ( 44,45). Approximately 60% 
of the genetic susceptibility to type 1 diabetes is thought to be related to HLA genes 
( 46). However, at least 11 other loci have been reported to be involved , with nearly 
10% of the genetic predisposition being accounted for by the flanking region of the 
insulin gene on chromosome 11 ( 45) . 
The pathogenesis of type 1 diabetes may result from autoimmunity reflected 
by autoimmunity reflected by autoantibodies against insulin ( 44). Approximately 90-
95% of type 1 diabetics have antibodies against one or more pancreatic beta cell islet 
components (45). Moreover, 3.5-4% of first-degree relatives without type 1 diabetes 
also have circulating antibodies ( 45) . The pathophysiology behind type 1 diabetes 
involves total destruction of the pancreatic beta cells resulting in complete 
dependence on exogenous insulin (44) . 
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Typ e 1 diabetes usually occurs before 30 years of age (44,45). The annual 
incid ence rate of type l diabetes is l 8.2 cases /100 ,000 people under the age of 20 
(45). Incid ence rate is lower in African Americans, Hispanic s, Asian Americans, and 
American Indians as compared to Caucasians ( 45). The annual prevalence rate of 
type l diabetes is l case /590 people under the age of 20 (45). Approximately 5-10% 
of people with diabetes have type 1 diabete s (44 ,45,46 ). The clinical signs and 
sympto ms identified in type l diabetics prior to the presentation of type 1 diabete s 
includ e: polyuria , polydipsia, fatigue, polyphagia , blurred vision, persistent 
hyperglyce mia , dehydration , ketoacidosis , significant weight loss, irritability , and 
fat igue (45). 
Type 2 diabetes is the most common type of diab etes and accounts for about 
90% of diabetic patients in the United States ( 44,45,46). Type 2 diabete s is a 
heteroge neou s disease of unknown etiology primarily manifested through 
enviromne ntal factors that may interact with susceptibility genes ( 45 ,46). Genetic 
suscep tibility to type 2 diabetes is enhanced through enviro1U11ental factors such as 
seden tary living and obesity ( 45 ,46). A type 2 diabetic with polyge nic defects are 
manifested via insulin deficiency, impair ed beta cell insulin secretion, and visceral 
obesity ( 45) . The developm ent of type 2 diabetes involves reduced cellular insulin 
secret ion, diminished liver , muscle , and adipose tissue sensitivity to insulin , and 
impaired insulin action that cannot compensate for increased serum glucose 
concentrations ( 45,46,48). 
Type 2 diabetes is multifactorial and requires both enviro1m1ental and genetic 
factors ( 46 ,49). A type 2 diabetic phenot ype can develop in persons with normal 
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insulin sensitivity who have a monogenic defect that impairs beta cell function or 
in persons who have one of severa l polygenic defects in which obesity, insulin 
resistance , and impaired beta cell insulin secretition are all part of the altered 
metabolic state (49). Approximately 85% of the diabetic population has polygenic 
defects ( 49). Moreover , environmental conditions can influence both monogenic and 
polygenic defects ( 49). 
A treatment regimen to control serum glucose levels must be administered 
(45,46). Personalized treatment will depend on the age of the patient, years of 
ant icipated survival, other health conditions, and the compliance of the patient to 
specific treatment regimens (45,46). Diet therapy alone or concomitantly used with 
ora l pharmacological agents may be used as treatment to reduce hyperglycemia 
(45 ,46). Over time , total exogenous insulin dependence may result (46). Although 
type 2 diabetes can occur at any age, type 2 diabetes has been observed increasingly 
among children as a consequence of the emerging epidemic of childhood obesity 
(46). 
Worldwide , the prevalence of diabetes is estimated to double within the next 
25 years and will affect approximately 300 million people by the year 2025 ( 46). 
More than 80% of the estimated 300 million people will suffer from type 2 diabetes 
( 46) . Chronic diabetes often leads to serious medical complications. Retinopathy , 
neplu·opathy , and neuropathy are long-term complications of diabetes and may be 
indicators of diabetes severity and poor glycemic control ( 44,45,46). 
Retinopathy affects greater than 6 out of 10 type 1 diabetics (46). It is 
estimated that 70-100% of type 1 diabetic s acquire retinopathy (50). In addition, 60 % 
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of type 2 diabetics experience some degree of retinopathy (51). Retinopathy is 
normally observed in type 2 diabetics having the disease for more than 20 years 
(44,46). There are two types of retinopathy associated with diabetes: nonproliferative 
and proliferative (46,51). Nonproliferative is considered a mild form of retinopathy 
and is also the most common form of retinopathy. Nonproliferative retinopathy 
occurs when blood vessels in the retina become weak and swelling resulting in 
bulging or fatty deposition of the vessels (46). Nonproliferative retinopathy does not 
cause visual disturbances unless associated with macular edema (44,45). Proliferative 
retinopathy occurs when blood vessels in the retina become damaged resulting in 
bleeding and closing off of microaneurysms and hard exudates (44,45,46). Moreover, 
the retina may compensate with new blood vessels, or they may in turn bleed. If 
heavy bleeding results or if bleeding occurs in certain areas of the eye, vision may be 
altered or impaired. New blood vessels can also form scar tissue that can push or pull 
on the retina distorting vision (46). 
The diabetic person is twenty times more likely to develop nephropathy than a 
person without diabetes (46). Greater than 3 out of 10 people with type 1 diabetes 
and nearly 1 in 10 people with type 2 diabetes will experience nephropathy (46). 
Nephropathy is characterized by proteinuria, hypertension, edema, and renal 
insufficiency (45) . Nephropathy can lead to kidney failure . In the United States, 
diabetes is the leading cause of kidney failure (46). Kidney failure is four times more 
common in African Americans with diabetes than in Caucasians with diabetes (46). 
ln addition, kidney failure is four to six times more common in Hispanics and six 
times more common in American Indians with diabetes than in Caucasians with 
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diabetes (46). It may be that African Americans, Hispanics, and American Indians 
experience kidney failure secondary to diabetes at a higher ratio than Caucasian 
Americans, due to the higher prevalence rate of diabetes (46). Approximately 40% of 
people beginning dialysis in the United States has diabetes (45). Of that percentage 
group, half have type 1 diabetes (45). 
Diabetes is an independent risk factor for peripheral neuropathy (52). High 
serum glucose levels can damage nerves by weakening capillary walls that nourish 
nerves, which then can lead to neuropathy (46). Depending on the degree and 
severity of neuropathy , gastroparesis, peripheral neuropathy, and urinary incontinence 
and dysfunction secondary to a neurogenic bladder, etc. can occur (44,46). Sensory 
nerve damage of the feet may lead to loss of sensation in the feet, which then may 
lead to ulcerations and infections of the feet. In addition, high serum glucose levels 
can reduce blood circulation to the feet by arterial constriction and vascular 
insufficiency thus impairing wound healing. If ulcerations of the feet are left 
untreated, foot amputations often result (44,45 ,46). Approximately 60,000 foot 
amputations are pe1formed annually in the United States (46). 
Other complications of diabetes resulting from blood vessel damage are 
coronary artery disease and stroke (44,46,52,53,54). Type 2 diabetes is an 
independent risk factor for macrovascular disease (44,55). Vessel damage incurred 
by high serum glucose levels increases the risk for arterial plaque formation. Vessel 
damage also increases arterial pressure leading to reduced blood circulation (44,46). 
Coronary heart disease alone is the direct cause of 77 ,000 deaths annually in the 
United States among people with diabetes (46). Cerebrovascular accidents affect 
400,000 people in the United States annually. Of which, 25% do not survive the 
incident (52) . 
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Although the exact etiology of the pathogenesis of type 1 diabetes and type 2 
diabetes in unclear, there are several factors that increase risk of developing diabetes. 
The chance of acquiring type 1 diabetes or type 2 diabetes increases if a family 
member has type 1 diabetes or type 2 diabetes ( 45,46). For example , if one identical 
twin develops diabetes, the likelihood of the other twin developing diabetes is 25-
50% ( 45). This risk or developing diabetes for the other twin is in contrast to a 0.4% 
risk in the general population , a 15% risk to a human leukocyte antigen (HLA) 
identical sibling , and a 1 % risk in an HLA nonidentical sibling ( 45). 
Exces s body weight is a strong risk factor for developing type 2 diabetes 
(32, 45,46,56,57). Greater than 8 out of 10 persons with type 2 diabetes are 
con sidered overweight ( 46) . The higher the proportion of fatty tissue in the body , the 
greater the resistance to insulin muscle and tissue cells experience ( 46 ,5 8). Moreover 
the insulin resistance phenomenon is increased when excess visceral fatty tissue is 
concentrated in the abdomen area ( 46,58). However , persons with type 2 diabetes can 
improve serum glucose levels by moderate weight loss ( 46). 
Sedentary living is considered a risk factor for type 2 diabetes (32,46,56). 
About 70% of adults in the United States either do not engage in any physically 
activity or are considered sedentary (59) . Physical activity aids in maintaining 
appropriate body weights, utili zing serum glucose in the form of energy , sensitizing 
muscle and tissue cells to insulin, increasing blood flow and vessel circulation, and 
increasing muscle mass (32,46). In nom1al conditions , approximately 70-90% of 
serum glucose is absorbed in muscle tissue ( 46). Consequently, lack of physical 
activity may lead to reduced muscle mass and hence, impaired serum glucose 
absorption in muscle tissue. Physical activity, independent of obesity, has been 
shown to decrease the risk for type 2 diabetes (59). 
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The likelihood of acquiring type 2 diabetes increases with age. Most notably , 
after the age of 45, the risk of developing type 2 diabetes increases ( 46). It is 
estimated that 1 in 5 Americans older than 65 years of age have type 2 diabetes ( 46). 
The increased risk of developing type 2 diabetes as people age may be partly due to 
less engage ment in physical activity and hence, less muscle mass, and weight gain 
(46). 
Type 2 diabetes is more apparent in Hispanic, African American, and 
American Indian populations in the United States (44). Furthermore, type 1 diabetes 
is more common in Caucasians in the Unite d States as well as in European countries 
( 45,46). The etiology of etlmicity and risk for developing diabetes is unclear ( 46). It 
may be that the etiology of ethnicity and diabetes is multifactorial. 
Diabetes Mellitus and Osteoporotic Hip Fractures 
Prior studies have not established a consistent association between 
osteoporotic hip fracture risk and diabetes mellitus (60). One reason for this is the 
limited amount of research conducted in this area. Until more data is gathered, debate 
will continue on the association between diabetes and osteoporotic hip fractures. One 
possible reason for Jack of association is insufficient data on bone mineral density 
(BMD) and the risk of osteoporosis in type 1 and type 2 diabetic patients (61). Due to 
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pathogenic differences in the onset and physiology of type 1 and type 2 diabete s, 
BMD statu s has often, but not always, supported different findings between type 1 
and type 2 diabetic patient s (6 1). Type 1 diabetes has long been assoc iated with low 
BMD (7,39,61 ,62,63,64,65,66). However , data on the relationship between type 2 
diabetes and BMD has not generated conclu sive findin gs (6 1,63,65,66). 
Heterogeneity of study participants , patient popu lations studied, measurement and 
study techniques , and inappropriate control groups or absence of control groups may 
accou nt for some of the inconclusive results previousl y reported (63,65). Some 
studi es have found similar or higher BMD in type 2 diabetes compared to nondi abetic 
control subject s (2,6 1,63,64,65,6 7). 
Differences in BMD levels betw een diabetic patients and controls have been 
atlrib uted to severa l factors (Table 2). Lower BMD in type 1 diabetes versu s type 2 
diabetes could result from rapid bone loss after the onset of type 1 diabetes, reduced 
peak bone mass, increased bone loss preceding peak bone mass , or a common 
genotype that makes type l diabetic s more susceptible to low BMD (61,68). Type 1 
diabetics may experience high rates of bone turnover and resorption that may be 
attributed to secondary hyperparathyroidism , hypomagnesemia , and decreased leve ls 
of 1-25-hydroxycholecalciferol (10,15,40,69,70). 
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Table 2. BMD and Diabetes Me llitus 
Type 1 Diabetes Type 2 Diabetes 
• Rapid bone loss after onset of • Insulin resistance before onset of 
diabetes diabetes may improve BMD 
• Reduced peak bone mass • High endogenous insulin may 
improve BMD 
• Increased bone loss after • Lower BMD with increased 
attainment of peak bone mass duration of type 2 diabetes 
• Common genotype lowering • Increased BMD in type 2 
BMD diabetics with excessive body 
weight 
• Lower BMD with increased 
duration of typel diabetes 
• Menstrual disorders and/or early 
menopause mav decrease BMD 
Elevated BMD levels observed in type 2 diab etics may be due to the period of 
insulin resistance before the onset of diabetes , which promotes hyperin sulinemia 
(63,66). High endogenous insulin levels may improve BMD (37). Hyperinsulinemia 
may also lead to increased BMD via its negative effect on sex hormone binding 
globuli n (63). Furthermore, obesity has been associated with increased BMD (37). 
It may be that one possible reason for the association between obesity and BMD is 
due to the positive relationship between obesity and elevated endogenous insulin 
levels (37). Obesity has also been associated with increased BMD due to increased 
adipose tissue s that produce estrogen (66,70). Bone turnover in type 2 diabetics with 
appropr iate glycemic control has been reported to be equal to or lower than bone 
turnover in persons without diabetes . Consequent ly, some studies have reported 
higher bone mass in type 2 diabetics than in nondiabetic controls (70). 
Insulin may act directly on bone tissue or insulin may work indirectly by 
binding to the insulin-like growth factor (IGF-1) receptor (63,65). In vitro studies 
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have demonstrated that insulin stimulates osteoblast cell proliferation involved in 
bone formation (37,65). Some cross-sectional studies have observed a positive 
association between BMD and insulin (37). In addition, the structural similarity 
between insulin and I GF-1 may play an important role in stimulating bone formation. 
I GF-1 is a polypeptide synthesized by bone cells and appears to regulate bone 
formation (35 ,37,38). Other cytokines and cellular messengers may also influence 
bone metabolism (63). Nonetheless, the duration of diabetes plays a critical role in 
increasing the risk of hip fracture given the lower BMD levels found among patients 
who have had diabetes for greater than 5 years (63). 
Age of menarche and menopause plays a key role in bone formation and 
osteoporosis in women (71 ). Approximately 30% of type 1 diabetic women report 
amenorrhea, polymenorrhea , and oligomenonhea throughout their reproductive years. 
This is double the prevalence of menstrual disorders observed among women without 
type 1 diabetes and, the differences are most pronounced when the onset of type 1 
diabetes is prepubescent. Menstrual disorders may result in lower BMD (11 ,22) . In 
addition, type 1 diabetes may promote early menopause causing lower BMD due to 
reduced levels of endogenous estrogen (71). 
Estrogen replacement therapy has been shown to lower the risk of 
osteoporosis development (2,4,22,24,25,72). However , postmenopausal estrogen use 
may influence carbohydrate metabolism and may be associated with type 2 diabetes 
(73). Some studies have reported no increase in incidence of type 2 diabetes with 
postmenopausal estrogen use (67,68). Other studies reported by Zhang et al. (73) 
have shown that estrogen was associated with lower fasting glucose and insulin 
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levels , but estrogen's use was related to a rise in 2-hour insulin and glucose levels 
(73). Zhang et al. (73) suggested that postmenopausal estrogen use may relate to 
deterioration of glucose tolerance and that longer usage of postmenopausal estrogen 
among current users may increase the risk for type 2 diabetes (72). Wilson et al. (72) 
reported that laboratory research conducted on ovariectomized rats with reduced 
estroge n levels foster insulin resistance. Yet, estrogen treatment administered to the 
rats restored insulin sensitivity. Furthermore, juvenile rats undergoing estrogen 
withdrawal experienced augmented fasting and glucose stimulated insulin levels (72). 
Some studies have also reported that estrogen replacement therapy may be associated 
with less insulin resistance in postmenopausal women with type 2 diabetes (72). Yet, 
postmenopausal estrogen use may be more common among leaner women (57). 
Hyperparathyroidism has been associated with decreased BMD (2, 7). Grey et 
al. (58) showed that postmenopausal women with primary hyperparathyroidism were 
significantly heavier , had a greater total body fat mass, and had proportionately more 
android fat than age-matched, eucalcemic controls (58). After adjustment for body 
weight, there remained modest bone mass reductions in the postmenopausal women 
with primary hyperparathyroidism (58). 
Primary hyperparathyroidism may lead to insulin resistance by promoting 
increased adiposity by select ively affecting skeletal muscle and not adipose tissue, 
thereby diverting carbohydrate to adipocytes (23,58). Insulin resistance may also 
occur due to the influence of the parathyroid hormone on adipocyte differentiation 
and function (58). Finally, insulin resistance may occur via the effects of obesity on 
calcium metabolism leading to secondary byperparathyroidism (58,74). Obesity 
increase s the risk of developing type 2 diabetes (32,44 ,46,56,57) . In addition , 
hyperparathyroidism has been associated with diabetes (75,76). 
It has also been reported that bisphosphonates may increase BMD in type 2 
diabetic persons via apoptosis of osteoclast cells, reduced osteoclastic recruitment, 
and inhibition of osteoclastgenesis resulting in decreased bone resorption ( 66). 
Chung et al. (66,77) suggested that HMG-CoA reductase inhibitors increase new 
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bone formation in skeletal tissue by osteoblasts in both in vitro cell culture systems 
and in vivo mice experiments (66,77). A proposed mechanism for bone formation 
involves an increase in expression and synthesis of bone morphogenetic protein 2 that 
may play a role in fracture repair and bone regeneration (66,77). 
Factors other than BMD may also impact hip fracture risk (Table 3). Diabetes 
is associated with increased disability in postmenopau sal women (2,78). Physical 
disability , loss of independence , and diminished quality of life may increase hip 
fracture risk (78). Greater than 50% of older people with diabetes have reported 
some degree of physical disability (78). Functional disability may lead to further 
complication s of diabetes including hyperglycemia, obesity, cardiovascular disease , 
peripheral vascular disease , depression , arthritis, and limited physical activity (78). It 
is possible that diabetic complications have a direct impact on hip fracture risk. 
Osteoporosis associated with type 1 diabetes and type 2 diabetes is worse in people 
with poor glycemic control (3,63,79). Poor glycemic control may result in 
hypercalciuria leading to negative calcium balance and secondary 
hyperparathyroidism. Consequently , bone resorption and bone loss may ensue (79). 
Table 3 Diabetes Mellitus and Its Complica ions May Increase Hip Fracture Risk 
Type l Diabetes Type 2 Diabetes 
• Physical disability • Physical activity 
• Loss of independence • Loss of independence 
• Decreased quality of life • Decreased quality of life 
• Hyperglycemia • Hyperglycemia 
• Hypoglycemia • Hypoglycemia 
• Cardiovascular disease • Cardiovascu lar disease 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
Peripheral vascular disease 
Depression 
Arthritis 
Increased low-impact fall rates 
Decreased neurological activity 
Visua l impairment 
Poor glycemic contro l 
Polyuria and nocturia 
Hyperparathyroidism 
Thyrotoxicosis 
• Peripheral vascular disease 
• Depression 
• Art hriti s 
• 
• 
• 
• 
• 
• 
• 
Incre ased low-impact fall rates 
Decreased neurological activity 
Visual impairment 
Poor glycemic contro l 
Polyuria and nocturia 
Hyperparathyroidism 
Sedentary life style 
Thirty percent of the conununity-dwelling elderly pop ulation in developed 
countries fall at least once a year and 10-20% fall twice or more (29). The effect of 
elevated fall frequency and the fact that over 30% of elderly women have 
osteoporosis has led to increased rates of osteoporotic fractures with increasing age 
(29,80) . Approximate ly 90% of hip fractures result from falling (14,80) . Diabetic 
patients may be at increased risk of falls and consequently increased risk for hip 
fracture (2,29,39,81,82,83,84). Increased fall rates may be due to hypoglycemic 
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episodes (84). Kennedy et al. (84) reported that diabetic patients treated with insulin 
therapy were at increased hip fracture risk possibly due to hypoglycemic mechanism s 
(84). Hypoglycemia can impair visual acuity, which may lead to increa sed fa ll 
incidence (7). Some studies have suggested that physical activity and certain 
regimens , such as weig ht-b earing activities , may reduce the risk for fa lling 
(2,28,29,30,32). Weig ht-b earing act ivity in older and frai l persons impro ves muscle 
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strength and mobility (29,30). Yet, physical activity may increase risk for falls due 
to skeletal muscle movement that displaces the body's center of gravity (29). In 
particular, vigorous physical activity , especially in the elderly and those with 
functional disabilities, may yield the highest risk for fall-related fractures (31 ). 
Physical activity has long been associated with increasing insulin sensitivity 
and decreasing abdominal adiposity and fat deposition (32). A sedentary lifestyle is 
considered a major risk factor for type 2 diabetes (7,32) . Neurologic , vascular, and 
ophthalmic complications due to diabetes severity have also been shown to increase 
fall rates as well as hip fracture risk (7, 84). 
Diabetic retinopathy is the third leading cause of blindness (82). In addition, 
diabetes is the leading cause of adult blindness in the United Sates (43,44). Diabetic 
retinopathy leads to visual impairment and predisposition to falls and hip fractures 
(2 ,7 ,10,68 ,82). Yet, Ivers et al. (64) found that even after adjustment for visual 
impairment, their data concluded that there remained a significant association 
between diabetic retinopathy and hip fracture risk (64). The only proven prevention 
of diabetic retinopathy is strict glycemic control. Even then, about 12% of diabetics 
still develop retinopathy when following strict glycemic treatment (50). Diabetic 
related visual disability may increase noncompliance of diabetic patients to treatment 
regimen, difficulties in self-administration of insulin and oral pharmacological 
treatments , difficulties in glucose monitoring, and inability to self-screen for diabetic 
complications such as foot ulceration (82). Such problems, exacerbated by visual 
impairment, may have a profound impact on glucose control, disease burden, and 
consequently hip fracture risk. Ivers et al. (64) reported an increased risk of fracture 
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with diabetic retinopathy, advanced cataract, longer diabetes duration, and insulin 
treatment compliance (64). To complicate matters further, Schaumberg et al. (83) 
reported risk of cataract increased in persons with higher body mass indexes, taller 
persons, and persons with greater amounts of abdominal adiposity (83). Higher body 
mass indexes and greater amounts of abdominal adiposity are associated with 
development of type 2 diabetes (6,32,46,56). 
There appears to be a relationship between duration of diabetes and poorer 
vision due to retinopathy and cataract formation (7 ,64,82). Fifty percent of 
Americans aged 65 to 74 years of age have some form of cataract (51). Cataract can 
lead to simulation affecting distance vision, glare related vision loss, and contrast 
difficulty (51). Thus , cataract development in diabetes persons may lead to increased 
fall rates due to vision impairment. 
The EURODOAB Prospective Complications Study showed that retinopathy 
developed in 56 % of diabetics within 7 years. Incidence of retinopathy peaked 
between 10 and 20 years of baseline diabetes duration (50). The impact of diabetic 
retinopathy on hip fracture risk may be more pronounced in diabetic patients with an 
early onset of the disease due to increased overall incidence of cataract and 
retinopathy (64,82). 
Peripheral neuropathy frequently occurs in the diabetic population and is the 
leading cause of peripheral neuropathy in developed nations (2,84,85). Peripheral 
neuropathy increases foot ulceration and lesions (7,52 ,84,86). Not only does 
peripheral neuropathy increase foot ulceration and lesions, but also motor and sensory 
neuropathy predisposes the patient to infection (52). Consequently , infection may in 
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turn lead to further exacerbation of food ulceration and lesions. Peripheral artery 
disease leads to increased risk of disability and physical functioning (78, 79,86). 
Impaired physical functioning, in particular lower extremity functioning, leads to 
increased fall rates and hence, increased hip fracture risk. Peripheral neuropathy 
alters coordination and balance, resulting in reduced gait and decreased reflexes 
(2,68,80,81,86). Another complication that may be present when alterations occur in 
gait and balance is polyuria and nocturia , which may also increase the risk of falling 
(7) . Some studies have also reported that peripheral artery disease in diabetics 
progresses at a faster rate than in nondiabetics with peripheral artery disease (84). 
Two common endocrine problems in the diabetic population that may lead to 
osteoporosis include thyrotoxicosis and hyperparathyroidism (75,76). 
Thyrotoxicosis , namely Grave's disease, develops after the onset of diabetes in type 1 
diabetic patients. The development of thyrotoxicosis increases with age and primarily 
occurs in postmenopausal women. Thyrotoxicosis has been suggested to be a cause 
of osteoporosis (75,76). Furthermore, persons with Grave's disease and type 1 
diabetes have been reported to share a common HLA genotype (76). 
Hyperparathyroidism occurs with nearly the same frequency in type 1 as type 2 
diabetics. Autoimmune hyperthyroidism is more common in type 1 diabetics and 
may be responsible for lower BMD in type 1 diabetic patients (76). Secondary 
hyperparathyroidism , hypomagnesaemia, and decreased levels of 1-25-
hydroxycholecalciferol may increase bone turnover and bone resorpt ion in type 1 
diabetics (10, 15,40,69, 70). 
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One of the primary risk factors for type 2 diabetics is obesity (7,44,46,70). 
Obese postmenopausal women have higher endogenous estrogen production and 
lower levels of sex hormone binding globulin that can increase BMD and lower hip 
fracture risk (11,65). Larger muscle in obese persons requires more work to move 
body mass, which may stimulate bone formation (11 ). Excess adipose tissue 
surrounding the femoral hip may serve as a protector in the act of a fall and therefore 
reduce the risk for hip fracture (11). 
RESEARCH OBJECTIVE 
The objective of this study was to establish a relationship between type 2 
diabetes mellitus and osteoporotic hip fractures. Therefore, the hypothesis that was 
tested is that type 2 diabetes is associated with increased risk of osteoporotic hip 
fracture. 
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MATERIALS AND METHODS 
Data Collection 
The Utah Study of Nutrition and Bone Health (USNBH) is a case-control study 
conducted in Utah during 1991-2001 to determine risk factors for osteoporotic hip 
fracture. All study participants were determined from Utah residents aged 50-90 
years. The average age was 76.36 (n= l 779) for females and 74.21 (n=811) males , 
respectively. Age (within 5 years of cases) and sex matched controls, whom at 
baseline never had a hip fracture, were randomly selected from the Utah Drivers 
License pool if less than 65 years of age and the Medicare databases if greater than 65 
years of age. Cases were obtained from 18 Utah hospital databases to validate hip 
fracture status. Interview-given questionnaires and picture-sort food frequency 
questionnaires were administered to participants in the study. All variables used in 
the statistical analysis were defined in the USNBH database obtained by the 
questionnaires administered to USNBH participants at the time of the study. 
Potential variables included, but were not limited to, age, gender, weight, height, 
body mass index (weight in kg/height in m2), smoking status, estrogen use, alcohol 
status , physical activity, intake of certain vitamins and minerals, cognitive function, 
statin use, glucocorticoid steroids , economic status, education level, stroke, 
cardiovascular disease , and thyroid function. Based upon this information, 
independent variables were identified that could potentially affect the occurrence of 
hip fracture. Specific variables selected for analysis were sex, body mass index (BMI) 
calculated from participant reported weight and height , diabetes, smoking status , 
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alcohol usage , physical activity , education level , and estrogen use in women 
subjects only. Type 2 diabetes participants were classified by the age of onset of 
diabetes. Type 1 diabetes typically develops before 30-years-of-age ( 44,46). 
Therefore, the age of 30 was the cut off point for the classification of diabetes type. 
Greater than 30 years of age was used to distinguish type 2 diabetes. Type 1 patients 
were dropped from the study because of insufficient numbers for statistical analyses 
(n=l 0). Only the type 2 diabetic population was used in this study. 
Potential participants with high impact trauma ( considered a fall from greater than 
chair height or impact fractures sustained from vehicular accidents) and a low Mini-
Mental State Examination (MMSE) score of less than or equal to 17 were excluded 
from the data set (11=150). 
Statistica l Analyses 
Contingency tables were calculated and chi-square analysis was used to compare 
the expected contingency table to the observed contingency table. Logistic regression 
analysis and modeling techniques were used to determine the associations between 
type 2 diabetes and hip fracture risk. Initially odds ratios were used to evaluate the 
risk of hip fracture, and then the analyses were stratified by gender and BMI groups. 
The dependent variable in the models was hip fracture which had two values, 
fract=l (confirmed hip fracture) and fract=O (no hip fracture). The dependent 
variable was binary (0 or 1). The independent variables were discrete in nature 
instead of continuous. 
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Because of the discrete natme of the data, the data was lo git transformed and 
logistic regression analysis was used. The logistic regression model used in this study 
was: 
Ln {Y=[Prob(fract = l )]/[Prob(Fract=O)] }=BO+B 1 *XI +B2*X2+ ....... +Bn*Xn 
The X's were the independent variables. The B's were the logistic regression 
coefficients. Their estimates were represented by the b's. The B's represent the 
original unknown parameter, while b was its estimate. 
The left-hand side of this relationship is known as the logit transformation of a 
probability. It is also called the log-odds ratio. The odds ratio gives the linear 
relationship between the dependant variable and the independent variable. 
All of the variates used in the statistical modeling were defined in the Utah Study 
of Nutrition and Bone Health (USNBH) database obtained by from questionnaires 
administered to USNBH participants at the time of the study. All statistical analyses 
were conducted with SAS statistical software programs (SAS System Ver 8.02). 
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RESULTS 
As depicted in Table 4, hip fracture was not associated with education levels (p > 
0.05) in both genders. Physical activity decreased the risk of hip fracture for women 
(p < 0.0001) and for men (p = 0.001). Smoking status and alcohol use were 
associated with the occurrence of hip fracture in women , but the association was not 
significan t in men. Estrogen use decreased hip fracture risk in women (p < 0.0001) in 
former or current users. 
The risk of hip fracture was associated with type 2 diabetes. Among females, type 
2 diabetes was more prevalent among cases vs. controls (15.6% vs. 11.7 %; p=0.02). 
In the smaller number of men, the difference was similar (17.7% vs. 14.6%) but was 
not significant. The significant correlation was primarily found in females in which 
the risk of hip fracture increased accompanied with the onset of type 2 diabetes. As 
indicated by the odd-ratios listed in Tables 5 and 6, the values of the odds-ratios for 
either women or men were larger than one, indicating an increased risk of hip fracture 
in people with type 2 diabetes. However, in males , there was a wide range of 
variation for the odds-ratio, ranging from 0.9 to 2.0, which indicates that the 
association of type 2 diabetes with hip fracture was most likely stronger in females 
than in males , or that the smaller number of males resulted in lower statistical power 
to detect a significant association. 
Considering BMI, hip fracture risk showed different patterns with respect to 
gender. In Table 7, females with a BMI larger than 30 had an odds-ratio of 2.0. 
Females with a BMI between 25 to 30 had an odds-ratio of 1.3. This indicated that 
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along with the increase of BMI, there was a significant association between hip 
fracture and type 2 diabetes and an increase in hip fracture risk. On the contrary , in 
Table 8, males with a BMI larger than 30 had the smallest odds-ratio of 0.8 compared 
with males of the other groups , BMI < 25 and BMI between 25 to 30 with odd-ratios 
of 1.2 and 1.7, respectively . Considering that a significant association between hip 
fracture risk and type 2 diabetes was not found in males , a higher BMI in males could 
have a protective effect against hip fracture . 
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Tab le 4. Demographic and Lifesty le Characteristics of Cases and Contro ls by 
Gender; The Utah Stud of Nutrition and Bone Health ; 1997-2001 
Women Men 
Cases* Controls* Cases* Contro ls* 
(N=882) (N=897) (N=350) (N=46 I) 
Age (mean in yrs , SD) 76.7(9. l ) 76.0 (9.4) 74 .9 (9.5) 73.7 ( l 0.7) 
Weight (mean in kg, SD) 63.5(14.1) 68.7 (14.5) 80.0 (14.8) 82.6 (] 5.2) 
Height (mea n in m, SD) 1.6 (0. 1) 1.6(0. l ) 1.8 (0. 1) 1.8(0.l) 
Body mass index (mean in 24.2 (5.J) 26.4 (5. 1) 25.0(4.1) 26.4 (4.3) 
kg/n,2, SD) 
Educatio n Level (N, %) 
< 12 years 460 (52 .2) 454 (50.7) 161 (46.0) 204 (44.4) 
~ 12 yea r 422 (47 .9) 442 (49 .3) 189 (54.0) 256 (55.7) 
Physical Activity Level** (N, %) 
None 220 (24.9) 111 (12.4) 45 (] 2 .9) 41 (8.9) 
One 24 1 (27.3) 186 (20.8) 111 (3 1.7) 10 1 (21.9) 
Two 260 (29.5) 363 ( 40.5) 118 (33.7) 19 1 (41.4) 
Three 16 1 (18.3) 236 (26.3) 76 (21.7) 128 (27.8) 
p :S0.000 1 p S 0.001 
Smok ing (N, %) 
Never 682 (77.5 750 (83.6) 158 (45.1) 244 (2 .9) 
Forme r 138 ( 15.7) 123 (13.7) 154(44.0) 179 (38.8) 
Current 60 (6.8) 24 (2.7) 38 (] 0.9) 3 8 (8.2) 
p S 0.000 1 p S 0.075 
Alcohol Drinker (N, %) 
Never 636 (72.4) 713 (79.7) 154 (44.l) 226 (49. 1) 
Former 133 ( 15.2) 8 1 (9.1) 114 (32.7) 128 (27.8) 
Current 109 ( 12.4) JOI (11.3) 8 1 (23.2) 106 (23 .0) 
p S 0.0002 p S 0.27 
Estroge n Use (N, %) 
Neve r 456 (53 .0) 386 (43.7) 
Forme r 215 (25.0) 228 (25.8) 
Current 189 (22.0) 269 (30.5) 
p S 0.0001 
Type 2 Diabetes (N, %) 
No 740 (84.4) 789 (88.3) 288 (82.3) 392 (85.4) 
Yes 137 ( 15.6) 105(]1.7) 62 (17 .7) 67( 14.6) 
p S 0.02 p S 0.23 
*Significant differences between cases and controls were estab lished at p S 0.05 , p S 0 .01, and p S 0.000 1. 
**Physical Activity is categorized by use of heavy housework, yard work, or recreational act iv ity. Never, 
one, two, and three are ass igned level s based on engagement in exactly none, one , two, or all thr ee types of 
physical act ivities. 
37 
Table 5. Risk of Hip Fracture Associated with Diabetes Status, Stratified by 
G d U d. d An I . en er, na 1uste ays1s 
Women Men 
Status o f 
Type 2 Odds ratio Odds ratio 
Diabetes Cases (N) Controls (N) and 95% Cases (N) Controls (N) and 95% 
confidence confidence 
interval interval 
Type 2 137 105 1.4 62 67 1.3 
Diabetic 
Not Type 2 740 789 I. I - 1.8 288 392 0 .8 - 1.9 
Diabetic 
Table 6. Risk of Hip Fracture Associated with Diabetes Status, Stratified by Gender , 
Adjusted in Logistic Regression Models for Age, BMI, Physical Activity, Education 
L 1 E U . W S ki dAl h 1 U eve, strogen se m omen, mo ng,a n co 0 se 
Women Men 
Status of 
Type 2 Adjusted Adjusted 
Diabetes Case s (N) Controls (N) odds ratio Cases (N) Controls (N) odds ratio 
and 95% and 95% 
confidence confidence 
interval interval 
Type 2 137 105 l.7 62 67 l .4 
Diabetic 
Not Type 2 740 789 1.3 - 2.4 288 392 0.9 - 2.0 
Diabetic 
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Table 7. Risk of Hip Fracture Associated with Diabetes Status for Women , 
Stratified by BMI; Adjusted in Logistic Regression Models for Age, Estrogen Use, 
Physical Activity, Education Level, Smoking, and Alcohol Use 
BMI < 25 BMI 25 - 30 BMI > 30 
Status of (Wo men only) (Wo men on ly) (Women only) 
Type 2 
Diabetes Adjusted Adjusted Adjusted 
Cases Controls odds ratio Cases Controls odds ratio Cases Con trol s odd ratio 
(N) (N) and 95% (N) (N) and 95% (N) (N) and 95% 
confide nce confide nce confidence 
interval interval interval 
Type 2 49 25 1.5 44 37 1.3 37 40 2 .0 
Diabetic 
Not Type 2 473 362 0.9 - 2.7 190 260 0.8 - 2.2 65 149 1.2 - 3.5 
Diabetic 
Table 8. Risk of Hip Fracture Associated with Diabetes Status for Men , Stratified by 
BMI; Adjusted in Logistic Regression Models for Age , Physical Activity, Education 
L 1 S k' d Al h 1 U eve mo mg , an co 0 se 
BMI < 25 BMI 25 - 30 BMI >30 
Status of (Men only) (Me n only) (Men only) 
Type 2 
Diabetes Adjusted Adjusted Adjusted 
Cases Controls odds ratio Cases Controls odds ratio Cases Co ntrol s odd ratio 
(N) (N) and 95% (N) (N) and 95% (N) (N) and 95% 
confidence confidence confidence 
interval inter va l inter va l 
Type 2 27 21 1.2 26 24 1.7 9 21 0.8 
Diabetic 
Not Type 2 150 16 1 0.6- 2.2 102 172 0 .9 - 3.2 31 57 0.3 -2.l 
Diabetic 
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DISCUSSION 
This sh1dy supports the hypothesis that the risk of hip fracture is significantly 
associated with type 2 diabetes. The significant association was found primarily in 
females. This may be due to the higher number of female participants with type 2 
diabetes and not a consequence of gender. However, the odds-ratios for both male 
and fema les was greater than one, which indicates that type 2 diabetic s are at 
increased risk for hip fracture. Yet, the odds-ratio trends still indicate a stronger risk 
for type 2 diabetic females . These findings are in agreement with Nicodemus et al. 
(70) who reported that type 2 diabetic women have increased hip fracture risk 
compared to non-diabetic women (70). On the contrary, it has been reported that type 
2 diabetic women have a lower frequency of sustaining a hip fracture (65) . 
Furt hermore , F orsen et al. ( 60) found that type 2 diabetic women with a long duration 
of the disease were at increased risk for hip fracture. However, type 2 diabetic men 
with a shorter duration of the disease were found to have an in increase hip fracture 
risk (60). 
The findings also support previous research that physical activity decreases risk 
for hip fracture. Sedentary living is a strong risk factor for bone loss and fractures 
(2, 7, 10,22). Physical activity, in particular bone building exercises, help to maintain 
or possible increase BMD and thereby reduce fracture risk (29 ,30). Epidemiological 
studies have suggested that hip fracture risk decreases by 20% to 50% for physically 
act ive adults compared to sedentary adults in the United States (31 ). Even after 
achieving peak bone mass , bone tissue can adapt to mechanical loading promoting 
bone remodeling. If physical activity is absent, then reduction in bone mass often 
ensues (30,31 ). Other possible benefits of physical activity may include improved 
agility and coordination, as well as increased muscle strength that may lower the 
likelihood of experiencing a fall, and therefore reducing fracture risk (2,29 ,30,32). 
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Estrogen use in former and cmTent female users was significantly associated with 
decreased hip fracture risk . Estrogen deficiency due to menopause accelerates bone 
loss (2,4,24,25). BMD losses of 2-4% occur up to five to ten years after menopause 
in the absence of estrogen replacement therapy (2). 
Smoking status and alcohol usage were significantly associated with hip fracture 
risk in women but no such association was found in men. This may be due to the 
small sample size of male participants. Some studies have reported lower BMD and 
increased risk of fractures with cigarette smoking (2, 10). Excessive alcohol intake is 
a strong risk factor for bone loss and fractures (2, 15). Increased risk of fractures may 
also be due to loss of physical ability (2,10). Excessive alcohol intake may lead to 
protein and/or calcium malnutrition, reduced mobility , and hypogonadism (5). 
Chronic alcohol use increases fracture risk due to falls and hepatic disease (2). 
Hepatic encephalopathy, resulting in decreased cognitive ability, may lead to 
increased fall rates as a result of decreased functionality and cognition. 
Table 7 demonstrates that in female participants, that along with increased BMI , 
there was a significant association between hip :fracture and type 2 diabetes. Two of 
the primary risk factors for type 2 diabetes are obesity and sedentary living 
(7,44,45,46,70). Greater than 8 out of 10 persons with type 2 diabetes are considered 
overweight ( 46). The higher the proportion of fatty tissue in the body , the greater the 
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resistance to insulin in muscle and tissue cells ( 46,5 8). It may be that proper 
glucose control minimizes diabetic complications and is more correlated with body 
weight and physical activity levels. In addition, persons with type 2 diabetes can 
impro ve serum glucose levels by moderate weight loss ( 46). Therefore, increased 
body weight and sedentary living may contribute to poor glycemic control , diabetic 
complications and physical disability (2, 78). Physical disability, loss of 
independence , and diminished quality of life may increase hip fracture risk (78). 
Functional disability may lead to further complications of diabetes including 
hyperglycemia , obesity, cardiovascular disease , peripheral vascular disease, 
depre ssion, arthritis, and limited physical activity (78). It is possible that diabetic 
complications have a direct impact on hip fractme risk. Osteoporosis associated with 
diabetes is worse in people with poor glycemic control (3,63,79). Poor glycemic 
control may result in hypercalciuria leading to negative calcium balance and 
secondary hyperparath yroi dism. Consequently, bone resorption and bone loss may 
ensue (79). Diabetic complications increase hip fracture risk either directly or 
indirectl y. Poor glycemic control can also lead to hypoglycemic episodes resulting in 
increased fall rates and increased hip fracture risk (2,27, 76). Poor glycemic control 
also impacts visual acuity and can cause diabet ic retinopathy thereby increasing the 
likelihood of falling (2, 10,63, 77). 
Table 8 indicates that male participants with high BMis may have some 
protection against hip fractures for type 2 diabetics however; caution should be taken 
because statistical significance was not found. Adipose tissue surrounding the 
femoral hip may provide a protective cushion in the event of a fall (2,21 ,22) . 
Moreover, it has been suggested that the most consistent predictor of BMD is total 
body fat (22,23). Greater total body fat results in elevated BMD. 
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Of greater importance to future research is the fact that this study showed that 
type 2 diabetes is a risk factor for hip fracture, supporting the hypothesis of this 
research that type 2 diabetes increases risk for hip fracture. However , the case-
control design of this study carmot be used to unequivocally state that type 2 diabetes 
causes hip fracture. Rather , this study establishes that there is a strong association 
between hip fracture risk and type 2 diabetes. Type 2 diabetes is multifactorial and 
many underlying factors contribute to the development of type 2 diabetes. Many of 
these factors could pose a risk for hip fracture. 
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SUMMARY 
Osteoporotic hip fractures severely affect quality of life by dimjnishing 
functional capacity to perform routine activities (1,2,7). Critical prevention to delay , 
or eliminate susceptibility to hip fracture , must focus on high-risk populations and 
administering proper treatment (7). The diabetic population may be at high-risk for 
hip fractures due to the multifactorial nature of diabetes mellitus and osteoporosis 
(3,13). The focus ohms study was to perform a statistical analysis on various data 
collected in the Utah Study of Nutrition and Bone Health (USNBH) to determine 
whether there was an association between type 2 diabetes and mp fracture, wmch was 
the case based upon the analysis of the data in tlus study. Therefore , the hypothesis 
that type 2 diabetes is associated with increased risk of osteoporotic hip fracture is 
acceptable. The results and conclusions derived from the data may eventually lead to 
better therapy for treating and/or minimizing hip fracture incidence. 
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